| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4135012 | ADME | Cytotoxicity against golden hamster BHK21 cells assessed as decrease in cell viability after 72 hrs by MTT assay | Mesocricetus auratus | 31 | ALA4130485 | cell-based format | Scientific Literature | |
| 2. | ALA4135013 | Functional | Antiviral activity against Yellow fever virus 17D vaccine (Stamaril Pasteur J07B01) infected in golden hamster BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 to 4 days by MTT assay | Yellow fever virus 17D | 32 | ALA4130485 | organism-based format | Scientific Literature | |
| 3. | ALA4135014 | Toxicity | Selectivity index, ratio of CC50 for golden hamster BHK21 cells to EC50 for Yellow fever virus 17D | 26 | ALA4130485 | assay format | Scientific Literature | ||
| 4. | ALA4135015 | Functional | Antiviral activity against Dengue virus type 2 clinical isolate infected in golden hamster BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 to 4 days by MTT assay | dengue virus type 2 | 26 | ALA4130485 | organism-based format | Scientific Literature | |
| 5. | ALA4135016 | Functional | Antiviral activity against West Nile virus clinical isolate infected in golden hamster BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 to 4 days by MTT assay | West Nile virus | 26 | ALA4130485 | organism-based format | Scientific Literature | |
| 6. | ALA4135017 | ADME | Cytotoxicity against bovine MDBK cells assessed as decrease in cell viability after 72 hrs by MTT assay | Bos taurus | 31 | ALA4130485 | cell-based format | Scientific Literature | |
| 7. | ALA4135018 | Functional | Antiviral activity against Bovine viral diarrhea virus NADL ATCC VR 534 infected in bovine MDBK cells assessed as protection against virus-induced cytopathic effect after 3 to 4 days by MTT assay | Bovine viral diarrhea virus 1-NADL | 31 | ALA4130485 | organism-based format | Scientific Literature | |
| 8. | ALA4135019 | ADME | Cytotoxicity against human MT4 cells assessed as decrease in cell viability after 96 hrs by MTT assay | Homo sapiens | 31 | ALA4130485 | cell-based format | Scientific Literature | |
| 9. | ALA4135020 | Functional | Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 4 days by MTT assay | Human immunodeficiency virus 1 | 31 | ALA4130485 | organism-based format | Scientific Literature | |
| 10. | ALA4135021 | Functional | Antiviral activity against Reovirus 1 infected in golden hamster BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 to 4 days by MTT assay | Mammalian orthoreovirus 1 | 31 | ALA4130485 | organism-based format | Scientific Literature | |
| 11. | ALA4135022 | ADME | Cytotoxicity against African green monkey Vero 76 cells assessed as decrease in cell viability after 48 to 96 hrs by MTT assay | Chlorocebus sabaeus | 35 | ALA4130485 | cell-based format | Scientific Literature | |
| 12. | ALA4135023 | Functional | Antiviral activity against Human enterovirus B Faulkner ATCC VR 185 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 3 days by crystal violet staining-based plaque reduction assay | Human enterovirus B | 31 | ALA4130485 | cell-based format | Scientific Literature | |
| 13. | ALA4135025 | Functional | Antiviral activity against Enterovirus C Sabin ATCC VR 534 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 2 days by crystal violet staining-based plaque reduction assay | Enterovirus C | 31 | ALA4130485 | organism-based format | Scientific Literature | |
| 14. | ALA4135026 | Functional | Antiviral activity against Vaccinia virus Lister ATCC VR 1549 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 3 days by crystal violet staining-based plaque reduction assay | Vaccinia virus Lister | 31 | ALA4130485 | organism-based format | Scientific Literature | |
| 15. | ALA4135027 | Functional | Antiviral activity against Human herpesvirus 1 KOS ATCC VR 1493 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 3 days by crystal violet staining-based plaque reduction assay | Human alphaherpesvirus 1 | 31 | ALA4130485 | organism-based format | Scientific Literature | |
| 16. | ALA4135028 | Functional | Antiviral activity against Vesicular stomatitis virus Indiana ATCC VR 158 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 2 days by crystal violet staining-based plaque reduction assay | Vesicular stomatitis Indiana virus | 30 | ALA4130485 | organism-based format | Scientific Literature | |
| 17. | ALA4135029 | Functional | Antiviral activity against Human respiratory syncytial virus A2 ATCC VR 1540 infected in African green monkey Vero 76 cells assessed as protection against virus-induced cytopathic effect after 5 days by crystal violet staining-based plaque reduction assay | Human respiratory syncytial virus A2 | 32 | ALA4130485 | organism-based format | Scientific Literature | |
| 18. | ALA4135031 | Functional | Potency index, ratio of azauridine EC50 to compound EC50 for Yellow fever virus 17D vaccine (Stamaril Pasteur J07B01) | Yellow fever virus 17D | 30 | ALA4130485 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!